Genomic screening can ID undetected BRCA1/2 cancer risk
(HealthDay)—Exome sequencing-based screening may identify pathogenic and likely pathogenic (P/LP) BRCA1/2 variants that might otherwise remain undetected, according to a […]
» Read moreHome »